Exploring Desmin as a Potential Modifier in Duchenne Muscular Dystrophy–Associated Cardiomyopathy
Acta Physiologica · 2025
DOI: 10.1111/apha.70117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Physiologica, 2025. Verfasst von Brice-Emmanuel Guennec und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Biologie Paris-Seine (IBPS), UMR CNRS 8263, INSERM U1345, Development, Adaptation and Ageing, Sorbonne Université, Paris, France. Hauptthemen laut MEDLINE: Desmin, Muscular Dystrophy, Duchenne, Cardiomyopathies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sorbonne Université, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale.
Abstract (Originalsprache)
Aim
Duchenne muscular dystrophy (DMD), a rare X‐linked genetic disorder, is affecting skeletal and cardiac muscles due to the loss of the dystrophin protein. Modifier proteins, whose expression is altered in DMD patients, may influence disease progression. Desmin, a muscle‐specific intermediate filament protein, is increased in the skeletal muscle of mdx mice, a murine model of DMD with a mild phenotype. Here, we inquired whether desmin acts as a modifier in DMD‐associated cardiomyopathy.
Methods
Soluble and insoluble desmin levels were quantified in the hearts of two mdx mouse models (B10.mdx and D2.mdx), and GRMD dystrophic dogs. The expression of desmin‐regulatory proteins was also assessed in mdx mice. To assess the impact of desmin levels on the phenotype, we generated mdx mice either desmin‐deficient (mdx‐Des −/− ) or with reduced levels of desmin by introducing a heterozygous desmin knock‐out allele (mdx‐Des +/− ). Phenotypic analyses included cardiac function assessment and histological evaluation.
Results
In mdx mice, desmin was elevated in its insoluble, phosphorylated, and presumably filamentous form, while GRMD dogs with a severe DMD‐like phenotype showed no such increase. Desmin deficiency in mdx mice led to severely aggravated dystrophic features, including cardiac dysfunction and increased fibrosis. Moreover, partial desmin reduction in mdx‐Des +/− mice led to the abrogation of insoluble desmin increase and worsened the mild mdx dystrophic phenotype.
Conclusion
Increased filamentous desmin appears to be protective in mdx mouse hearts and may modulate the severity of DMD cardiomyopathy. These findings support a modifier role for desmin and highlight this protein as a potential therapeutic target for DMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut de Biologie Paris-Seine (IBPS), UMR CNRS 8263, INSERM U1345, Development, Adaptation and Ageing, Sorbonne Université, Paris, France.
- UMS28, Plateforme d'Expérimentation Cœur, Muscles, Vaisseaux, Sorbonne Université, Paris, France.
- Inserm U955-E10, IMRB, Université Paris Est, Ecole nationale vétérinaire d'Alfort, Maisons-Alfort, France.
- CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, Université de Lille, Lille, France.
- Centre de Recherche en Myologie, UMRS974, Sorbonne Université, Paris, France.
- Université Pars Cité, Paris, France.
ORCID-Profile: Brice-Emmanuel Guennec, Arnaud Ferry, Zhenlin Li
Förderung
- Sorbonne Université
- Centre National de la Recherche Scientifique
- Institut National de la Santé et de la Recherche Médicale
- French Muscular Dystrophy Association
Zitieren
APA
Guennec, B. E., Hovhannisyan, Y., Revet, G., Polat, S., Hassani, M., Mougenot, N., Barthelemy, I., Blot, S., Cieniewski-Bernard, C., Ferry, A., Kordeli, E., Li, Z., & Agbulut, O. (2025). Exploring Desmin as a Potential Modifier in Duchenne Muscular Dystrophy–Associated Cardiomyopathy. Acta Physiologica. https://doi.org/10.1111/apha.70117
Vancouver
Guennec BE, Hovhannisyan Y, Revet G, Polat S, Hassani M, Mougenot N, et al. Exploring Desmin as a Potential Modifier in Duchenne Muscular Dystrophy–Associated Cardiomyopathy. Acta Physiologica. 2025. doi:10.1111/apha.70117
BibTeX
@article{Guennec2025,
author = {Guennec, Brice-Emmanuel and Hovhannisyan, Yeranuhi and Revet, Gaëlle and Polat, Sila and Hassani, Medhi and Mougenot, Nathalie and Barthelemy, Inès and Blot, Stephane and Cieniewski-Bernard, Caroline and Ferry, Arnaud and Kordeli, Ekaterini and Li, Zhenlin and Agbulut, Onnik},
title = {Exploring Desmin as a Potential Modifier in Duchenne Muscular Dystrophy–Associated Cardiomyopathy},
journal = {Acta Physiologica},
year = {2025},
doi = {10.1111/apha.70117}
}
EUVIMED